There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...

A 2024 investigation demonstrated that while transient detection of donor-derived HIV in kidney transplant recipients occurs shortly after surgery, no sustained superinfection is observed in the ...

Unfortunately, the HIV pandemic still rages throughout the world, particularly in resource-poor countries such as those in sub-Saharan Africa, the Caribbean and parts of Asia. This fact should ...

Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and ...

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Yeztugo was approved by the FDA ...

The first cases of HIV in the U.S. were reported on June 5, 1981. HIV is a virus that attacks a person's immune system, making them vulnerable to disease.

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more t… ...